STUDY OF THE SAFETY, TOLERABILITY, PHARMACOKINETICS, PHARMACODYNAMICS AND EFFICACY OF RECOMBINANT HUMAN ALBUMIN IN PATIENTS WITH ASCITES DUE TO CIRRHOSIS

被引：0
|
作者：
Li, Wanyu [1 ]
Wang, Xinrui [1 ]
Gao, Yanhang, Sr. [1 ]
Pan, Yu [1 ]
Kong, Fei [1 ]
Niu, Junqi [1 ]
机构：
[1] First Hosp Jilin Univ, Dept Hepatol, Changchun, Peoples R China
来源：
HEPATOLOGY | 2021年 / 74卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
2094
引用
收藏
页码：1245A / 1245A
页数：1
相关论文
共 50 条
  • [1] Comparison of recombinant human albumin with human serum albumin: Safety, tolerability and pharmacodynamics
    Schindel, F
    Andresen, C
    Bosse, D
    JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 43 (09): : 1032 - 1032
  • [2] A randomized dose-escalation study on the safety, tolerability, immunogenicity, pharmacokinetics and pharmacodynamics of a novel recombinant human albumin in healthy subjects
    Li, Cuiyun
    Xiang, Wei
    Wu, Min
    Zhang, Hong
    Cheng, Jianqiu
    Yang, Tao
    Mai, Jiajia
    Chi, Xiumei
    Gao, Xiuzhu
    Ding, Yanhua
    Niu, Junqi
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2021, 165
  • [3] A meta-analysis of the efficacy and safety of human serum albumin treatment in patients with ascites due to cirrhosis undergoing drainage
    Zheng, Ying-Jun
    Zhuo, Shi-jie
    Huang, Bin
    Su, Song
    ASIAN JOURNAL OF SURGERY, 2021, 44 (08) : 1116 - 1117
  • [4] Efficacy and Safety Profile of Human Serum Albumin in Patients with Ascites Due to Cirrhosis A Systematic Review and Meta-Analysis
    Shrestha, D. B.
    Budhathoki, P.
    Sedhai, Y.
    Baniya, R.
    Awal, S.
    Yadav, J.
    Awal, L.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [5] The pharmacokinetics, pharmacodynamics, clinical efficacy, safety and tolerability of linaclotide
    Lee, Noel
    Wald, Arnold
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2011, 7 (05) : 651 - 659
  • [6] Cariprazine: chemistry, pharmacodynamics, pharmacokinetics, and metabolism, clinical efficacy, safety, and tolerability
    Citrome, Leslie
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2013, 9 (02) : 193 - 206
  • [7] Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of Recombinant Neorudin, a New Anticoagulant Drug in Patients With Acute Coronary Syndrome
    Liu, Yu-bin
    Liang, Yan
    Liu, Hui-chen
    Feng, Guang-xun
    Zhou, Xing-chen
    Zhang, Lin
    Zhang, Xiao-long
    Li, Qiang
    Ren, Bo-yuan
    Xia, Xia
    Zhu, Jun
    Wu, Chu-tse
    Jin, Ji-de
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2024, 13 (11): : 1189 - 1197
  • [8] Preliminary efficacy, safety, pharmacokinetics, pharmacodynamics and quality of life study of pegylated recombinant human arginase 1 in patients with advanced hepatocellular carcinoma
    Thomas Yau
    Paul N. Cheng
    Pierre Chan
    Li Chen
    Jimmy Yuen
    Roberta Pang
    Sheung Tat Fan
    Denys N. Wheatley
    Ronnie T. Poon
    Investigational New Drugs, 2015, 33 : 496 - 504
  • [9] Preliminary efficacy, safety, pharmacokinetics, pharmacodynamics and quality of life study of pegylated recombinant human arginase 1 in patients with advanced hepatocellular carcinoma
    Yau, Thomas
    Cheng, Paul N.
    Chan, Pierre
    Chen, Li
    Yuen, Jimmy
    Pang, Roberta
    Fan, Sheung Tat
    Wheatley, Denys N.
    Poon, Ronnie T.
    INVESTIGATIONAL NEW DRUGS, 2015, 33 (02) : 496 - 504
  • [10] Recombinant ADAMTS13 for Patients with Sickle Cell Disease: Design of a Phase 1 Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Study
    Patwari, Parth
    Nguyen, Van Anh
    Bhattacharya, Indranil
    Jain, Nisha
    BLOOD, 2021, 138
12345